BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18625703)

  • 41. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
    Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
    Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry.
    Snider JM; Snider AJ; Obeid LM; Luberto C; Hannun YA
    J Lipid Res; 2018 Jun; 59(6):1046-1057. PubMed ID: 29610123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
    Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
    J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceramide synthases at the centre of sphingolipid metabolism and biology.
    Mullen TD; Hannun YA; Obeid LM
    Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction.
    Hamada Y; Nagasaki H; Fujiya A; Seino Y; Shang QL; Suzuki T; Hashimoto H; Oiso Y
    J Nutr Biochem; 2014 Dec; 25(12):1309-16. PubMed ID: 25283329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.
    Abe A; Wu D; Shayman JA; Radin NS
    Eur J Biochem; 1992 Dec; 210(3):765-73. PubMed ID: 1483461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1.
    Wang F; Buckley NE; Olivera A; Goodemote KA; Su Y; Spiegel S
    Glycoconj J; 1996 Dec; 13(6):937-45. PubMed ID: 8981085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A role for the de novo sphingolipids in apoptosis of photosensitized cells.
    Wispriyono B; Schmelz E; Pelayo H; Hanada K; Separovic D
    Exp Cell Res; 2002 Sep; 279(1):153-65. PubMed ID: 12213223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of the sphingolipid ceramide in heat-shock-induced apoptosis of bovine oocytes.
    Kalo D; Roth Z
    Reprod Fertil Dev; 2011; 23(7):876-88. PubMed ID: 21871207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
    Dany M; Elston D
    J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells.
    Kiefer K; Carreras-Sureda A; García-López R; Rubio-Moscardó F; Casas J; Fabriàs G; Vicente R
    J Biol Chem; 2015 Jan; 290(5):2822-30. PubMed ID: 25519910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells.
    van Meer G; Stelzer EH; Wijnaendts-van-Resandt RW; Simons K
    J Cell Biol; 1987 Oct; 105(4):1623-35. PubMed ID: 3667693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
    Tserng KY; Griffin RL
    Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
    Bhat VK; Bernhart E; Plastira I; Fan K; Ghaffari-Tabrizi-Wizsy N; Wadsack C; Rechberger G; Eichmann T; Asslaber M; Spassova I; Verhaegen ME; Malle E; Becker JC; Sattler W
    J Invest Dermatol; 2019 Apr; 139(4):807-817. PubMed ID: 30399362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
    Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
    J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.
    Hernández-Corbacho MJ; Canals D; Adada MM; Liu M; Senkal CE; Yi JK; Mao C; Luberto C; Hannun YA; Obeid LM
    J Biol Chem; 2015 Oct; 290(42):25356-73. PubMed ID: 26318452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
    Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
    Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.